Because TP53 mutation is uncommon in CCRCC, a separate model excluding CCRCC samples was trained for TP53 mutation and used for multi-omics integration to improve the ability of sparse CCA to detect genuine biological signals correlating with TP53 mutation. The gene discussed is TP53; the disease is nonpapillary renal cell carcinoma.